Systolic heart failure - Globe Thesis

Keyword [Systolic heart failure] Result: 1 - 20 \| Page: 1 of 3
1.	Noninvasive Measurement Of Coronary Perfusion Pressure In Patients Of Dilated Cardiomyopathy With Chronic Systolic Heart Failure
2.	The Serum Levels Of Matrix Metalloproteinase2, 9(MMP-2, 9)in Patients Of Heart Failure
3.	Association Analysis Of The Plasma Levels Of Adiponectin, Brain Natriuretic Peptide And Cardiac Function In Patients With Chronic Systolic Heart Failure
4.	Research Of Neuregulin-1 Therapy In Systolic Insufficiency Heart Failure
5.	Protective Effects Of Neuregulin-1β On Chronic Contractibility Cardiac Failure And Correlative Mechanisms Research
6.	A Survey Of β Blocker's Use In Patients Of Chronic Systolic Heart Failure Or Coronary Heart Disease
7.	Yi Qi Yang Xin Granules On Chronic Systolic Heart Failure Clinical Research
8.	A PhaseⅡ, Randomized, Double-blind, Multi-center, Based On Standard Therapy, Placebo-controlled Study Of The Efficacy And Safety Of Recombinant Human Neurugulin-1βin Patients With Chronic Systolic Heart Failure
9.	Diastolic Heart Failure In The Western Medical Progress
10.	Relationship Between Plasma N-terminal Pro-B-type Natriuretic Peptide Levels And Metabolic Syndrome
11.	The Study On Pathogenesis And Drugs Prevention Effects Of Diastolic Heart Failure
12.	Role Of Multiorgan Impairment In Clinical Progress And In-hospital Outcome Of Hospitalized Patients With Chronic Systolic Heart Failure
13.	Acupoint Application Of Chinese Herbs In Adjuvant Treatment Of Chronic Systolic Heart Failure Curative Effect Observation
14.	Clinical Observation Of Shenfu Injection In The Treatment Of Systolic Heart Failure
15.	Usefulness Of Acoustic Cardiography In The Diagnosis Of Chronic Systolic Heart Failure
16.	Factors Affecting The Long-term Prognosis Of Elderly Patients With Chronic Systolic Heart Failure
17.	The Randomized, Double-blind, Multi-center, Based On Standard Therapy, Placebo-controlled Study Of The Efficacy And Safety Of Recombinant Oral Tolvaptan In Patients With Chronic Systolic Heart Failure
18.	Clinical Evaluation Of Levosimendan In Patients With Severe Systolic Heart Failure
19.	Study On Plasma MicroRNA-210in Patients With Systolic Heart Failure
20.	The Change Of N-terminal Pro-B-type Natriuretic Peptide And Red Cell Distribution Width In Patients With Chronic Systolic Heart Failure, And The Effect Of Levosimendan
<<First <Prev Next> Last>> Jump to